BHBrady Hunt

Brady Hunt

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Brady Hunt has a total of 92 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Fast Deformable Image Registration for Real-Time Target Tracking During Radiation Therapy Using Cine MRI and Deep Learning

    by Brady Hunt, Gobind S. Gill, Daniel A. Alexander, Samuel S. Streeter, David J. Gladstone, Gregory A. Russo, Bassem I. Zaki, Brian W. Pogue, Rongxiao Zhang


  • Open Access

    Lighting gel filters as low-cost alternatives for fluorescence imaging and optical system design

    by Alberto J. Ruiz, Mia K. Giallorenzi, Brady Hunt, Kimberley S. Samkoe, Brian W. Pogue

    Lighting gel filters are widely used in commercial industries, but their adoption in scientific applications is limited, despite their low cost and form factor advantages. Here, we compare the optical performance of lighting gel filters to commonly used dielectric and colored glass filters in terms of absorbance spectra, passband transmission, angle of incidence dependence, autofluorescence, and photostability. Further comparison is performed in both preclinical and clinical imaging applications. The results show that gel filters might be a superior filter choice in several optical systems, including compact designs and fluorescence imaging applications. Compact designs using gel filters could have a significant advantage for applications such as point-of-care diagnostics, smartphone device add-ons, and single-use fluorescent assays.


  • Open Access

    Multi-task network for automated analysis of high-resolution endomicroscopy images to detect cervical precancer and cancer

    by David Brenes, Cj Barberan, Brady Hunt, Sonia G. Parra, Mila P. Salcedo, Júlio C. Possati-Resende, Miriam L. Cremer, Philip E. Castle, José H.T.G. Fregnani, Mauricio Maza, et al.


  • Ultracompact fluorescence smartphone attachment using built-in optics for protoporphyrin-IX quantification in skin

    by Brady Hunt, Samuel S. Streeter, Alberto J. Ruiz, M. Shane Chapman, Brian W. Pogue

    Smartphone-based fluorescence imaging systems have the potential to provide convenient quantitative image guidance at the point of care. However, common approaches have required the addition of complex optical attachments, which reduce translation potential. In this study, a simple clip-on attachment appropriate for fluorescence imaging of protoporphyrin-IX (PpIX) in skin was designed using the built-in light source and ultrawide camera sensor of a smartphone. Software control for image acquisition and quantitative analysis was developed using the 10-bit video capability of the phone. Optical performance was characterized using PpIX in liquid tissue phantoms and endogenously produced PpIX in mice and human skin. The proposed system achieves a very compact form factor (3) and can be readily fabricated using widely available low-cost materials. The limit of detection of PpIX in optical phantoms was 0.99). Both murine and human skin imaging verified that in vivo PpIX fluorescence was detected within 1 hour of applying aminolevulinic acid (ALA) gel. This ultracompact handheld system for quantification of PpIX in skin is well-suited for dermatology clinical workflows. Due to its simplicity and form factor, the proposed system can be readily adapted for use with other smartphone devices and fluorescence imaging applications. Hardware design and software for the system is made freely available on GitHub (https://github.com/optmed/CompactFluorescenceCam).


  • High frame rate video mosaicking microendoscope to image large regions of intact tissue with subcellular resolution

    by Brady Hunt, Jackson Coole, David Brenes, Alex Kortum, Ruchika Mitbander, Imran Vohra, Jennifer Carns, Richard Schwarz, Rebecca Richards-Kortum

    High-resolution microendoscopy (HRME) is a low-cost strategy to acquire images of intact tissue with subcellular resolution at frame rates ranging from 11 to 18 fps. Current HRME imaging strategies are limited by the small microendoscope field of view (∼0.5 mm2); multiple images must be acquired and reliably registered to assess large regions of clinical interest. Image mosaics have been assembled from co-registered frames of video acquired as a microendoscope is slowly moved across the tissue surface, but the slow frame rate of previous HRME systems made this approach impractical for acquiring quality mosaicked images from large regions of interest. Here, we present a novel video mosaicking microendoscope incorporating a high frame rate CMOS sensor and optical probe holder to enable high-speed, high quality interrogation of large tissue regions of interest. Microendoscopy videos acquired at >90 fps are assembled into an image mosaic. We assessed registration accuracy and image sharpness across the mosaic for images acquired with a handheld probe over a range of translational speeds. This high frame rate video mosaicking microendoscope enables in vivo probe translation at >15 millimeters per second while preserving high image quality and accurate mosaicking, increasing the size of the region of interest that can be interrogated at high resolution from 0.5 mm2 to >30 mm2. Real-time deployment of this high-frame rate system is demonstrated in vivo and source code made publicly available.


  • Top Cited Papers
    Open Access

    Smartphone-based imaging systems for medical applications: a critical review

    by Brady Hunt, Alberto J. Ruiz, Brian W. Pogue

    Smartphone-based imaging (SBI) has been proposed for numerous biomedical applications, many of which use an optical attachment to augment or extend the native device capabilities (Fig. 1). In the past decade, the most common application for SBI has been diagnostic analysis of ex vivo specimens (i.e., point-of-care testing), which has utilized smartphones in a variety of microscopy and microfluidic detection schemes.1 – 4 SBI is also frequently proposed for noninvasive monitoring and diagnosis of externally accessible tissues, particularly in dermatological applications.5 More recently, SBI for minimally invasive procedures and treatment guidance has also been reported, including photodynamic therapy (PDT),6 – 9 endoscopy,10 – 13 in vivo microscopy,14 – 17 and surgery.18 – 22 As ex vivo diagnostic applications have been extensively reviewed elsewhere,1 – 4 this review focuses on SBI systems for real-time tissue imaging applications (i.e., in vivo monitoring, diagnosis, and treatment guidance). However, recent developments in ex vivo diagnostic system designs, which may have relevance in tissue imaging applications are also discussed for comparison and contrast.


  • Cervical lesion assessment using real‐time microendoscopy image analysis in Brazil: The CLARA study

    by Brady Hunt, José Humberto Tavares Guerreiro Fregnani, David Brenes, Richard A. Schwarz, Mila P. Salcedo, Júlio César Possati‐Resende, Márcio Antoniazzi, Bruno de Oliveira Fonseca, Iara Viana Vidigal Santana, Graziela de Macêdo Matsushita, et al.

    We conducted a prospective evaluation of the diagnostic performance of high‐resolution microendoscopy (HRME) to detect cervical intraepithelial neoplasia (CIN) in women with abnormal screening tests. Study participants underwent colposcopy, HRME and cervical biopsy. The prospective diagnostic performance of HRME using an automated morphologic image analysis algorithm was compared to that of colposcopy using histopathologic detection of CIN as the gold standard. To assess the potential to further improve performance of HRME image analysis, we also conducted a retrospective analysis assessing performance of a multi‐task convolutional neural network to segment and classify HRME images. One thousand four hundred eighty‐six subjects completed the study; 435 (29%) subjects had CIN Grade 2 or more severe (CIN2+) diagnosis. HRME with morphologic image analysis for detection of CIN Grade 3 or more severe diagnoses (CIN3+) was similarly sensitive (95.6% vs 96.2%, P = .81) and specific (56.6% vs 58.7%, P = .18) as colposcopy. HRME with morphologic image analysis for detection of CIN2+ was slightly less sensitive (91.7% vs 95.6%, P < .01) and specific (59.7% vs 63.4%, P = .02) than colposcopy. Images from 870 subjects were used to train a multi‐task convolutional neural network‐based algorithm and images from the remaining 616 were used to validate its performance. There were no significant differences in the sensitivity and specificity of HRME with neural network analysis vs colposcopy for detection of CIN2+ or CIN3+. Using a neural network‐based algorithm, HRME has comparable sensitivity and specificity to colposcopy for detection of CIN2+. HRME could provide a low‐cost, point‐of‐care alternative to colposcopy and biopsy in the prevention of cervical cancer.


  • Advances in technologies for cervical cancer detection in low-resource settings

    by Kathryn A. Kundrod, Chelsey A. Smith, Brady Hunt, Richard A. Schwarz, Kathleen Schmeler, Rebecca Richards-Kortum

    Introduction: Cervical cancer mortality rates remain high in low- and middle-income countries (LMICs) and other medically underserved areas due to challenges with implementation and sustainability of routine screening, accurate diagnosis, and early treatment of preinvasive lesions. Areas covered: In this review, we first discuss the standard of care for cervical cancer screening and diagnosis in high- and low-resource settings, biomarkers that correlate to cervical precancer and cancer, and needs for new tests. We review technologies for screening and diagnosis with a focus on tests that are already in use in LMICs or have the potential to be adapted for use in LMICs. Finally, we provide perspectives on the next five years of technology development for improved cervical cancer screening and diagnosis in LMICs. Expert opinion: Innovation toward improved molecular and imaging tests is needed to enable effective, affordable see-and-treat approaches to detect and treat cervical precancer in a single visit. Current molecular tests remain too complex and/or costly for widespread use. Especially with imaging tests, decision support may improve performance of new technologies.


  • Open Access

    Is Proflavine Exposure Associated with Disease Progression in Women with Cervical Dysplasia? A Brief Report

    by Naitielle Pantano, Brady Hunt, Richard A. Schwarz, Sonia Parra, Katelin Cherry, Júlio César Possati‐Resende, Adhemar Longatto‐Filho, José Humberto Tavares Guerreiro Fregnani, Philip E. Castle, Kathleen Schmeler, et al.

    Proflavine is an acridine dye used with high‐resolution microendoscopy for in vivo diagnostic evaluation of cervical epithelial cells. However, there are concerns that even short‐term exposure of cervical tissue to dilute proflavine may increase cervical cancer risk. We performed a retrospective analysis of women referred for colposcopy to Barretos Cancer Hospital comparing the risk of cervical disease progression in those whose cervical tissue was (n = 232) or was not exposed (n = 160) to proflavine. Patients in both groups underwent treatment and follow‐up based on histopathologic results and per the local standards of care. Progression of disease was evaluated by comparing histopathology from the initial visit to the worst subsequent histopathology result from all follow‐up visits. Mean duration of follow‐up was 18.7 and 20.1 months for the proflavine‐exposed and controls groups, respectively. There were no significant differences in disease progression from normal/CIN1 to CIN2/3 or from any initial diagnosis to invasive cancer between the proflavine exposed and control groups overall. Risks of cervical dysplasia progression observed in this study are in agreement with those of the natural history of cervical cancer. Our results suggest that cervical exposure to dilute proflavine does not increase the risk of cervical precancer and cancer.


  • Open Access

    Diagnosing Cervical Neoplasia in Rural Brazil Using a Mobile Van Equipped withIn VivoMicroscopy: A Cluster-Randomized Community Trial

    by Brady Hunt, José Humberto Tavares Guerreiro Fregnani, Richard A. Schwarz, Naitielle Pantano, Suelen Tesoni, Júlio César Possati-Resende, Marcio Antoniazzi, Bruno de Oliveira Fonseca, Graziela de Macêdo Matsushita, Cristovam Scapulatempo-Neto, et al.

    Cervical cancer is a leading cause of death in underserved areas of Brazil. This prospective randomized trial involved 200 women in southern/central Brazil with abnormal Papanicolaou tests. Participants were randomized by geographic cluster and referred for diagnostic evaluation either at a mobile van upon its scheduled visit to their local community, or at a central hospital. Participants in both arms underwent colposcopy, in vivo microscopy, and cervical biopsies. We compared rates of diagnostic follow-up completion between study arms, and also evaluated the diagnostic performance of in vivo microscopy compared with colposcopy. There was a 23% absolute and 37% relative increase in diagnostic follow-up completion rates for patients referred to the mobile van (102/117, 87%) compared with the central hospital (53/83, 64%; P = 0.0001; risk ratio = 1.37, 95% CI, 1.14–1.63). In 229 cervical sites in 144 patients, colposcopic examination identified sites diagnosed as cervical intraepithelial neoplasia grade 2 or more severe (CIN2+; 85 sites) with a sensitivity of 94% (95% CI, 87%–98%) and specificity of 50% (95% CI, 42%–58%). In vivo microscopy with real-time automated image analysis identified CIN2+ with a sensitivity of 92% (95% CI, 84%–97%) and specificity of 48% (95% CI, 40%–56%). Women referred to the mobile van were more likely to complete their diagnostic follow-up compared with those referred to a central hospital, without compromise in clinical care. In vivo microscopy in a mobile van provides automated diagnostic imaging with sensitivity and specificity similar to colposcopy. Cancer Prev Res; 11(6); 359–70. ©2018 AACR.